Fore Kopi Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 2.1× Fore Kopi Indonesia Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (1.89M versus 613K). Which is the better fit depends on your goals.
| FORE | TSPC | |
|---|---|---|
Market Cap | 5.44T | 11.18T |
Volume | 1.89M | 613K |
Lot | 18.9K | 6.13K |
Turnover | 1.15B | 1.54B |
Average Price | 609.92 | 2,511.52 |
Value | 1.15B | 1.54B |
Indicative Equilibrium Price | 615 | 2,520 |
Indicative Equilibrium Volume | 1.29K | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →